These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 36370373)
1. Severe congenital myasthenic syndrome with novel variants in the CHRND gene. Kondo H; Tsuji Y; Lee T; Saito Y; Nishino I Pediatr Int; 2022 Jan; 64(1):e15342. PubMed ID: 36370373 [No Abstract] [Full Text] [Related]
2. New compound heterozygous variants of the cholinergic receptor nicotinic delta subunit gene in a Chinese male with congenital myasthenic syndrome: A case report. Feng H; Zhou H Medicine (Baltimore); 2017 Dec; 96(51):e8981. PubMed ID: 29390429 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of salbutamol monotherapy in slow-channel congenital myasthenic syndrome caused by a novel mutation in CHRND. Tawara N; Yamashita S; Takamatsu K; Yamasaki Y; Mukaino A; Nakane S; Farshadyeganeh P; Ohno K; Ando Y Muscle Nerve; 2021 Apr; 63(4):E30-E32. PubMed ID: 33428214 [No Abstract] [Full Text] [Related]
4. Severe congenital myasthenic syndrome associated with novel biallelic mutation of the CHRND gene. Bonanno C; Rodolico C; Töpf A; Foti FM; Liu WW; Beeson D; Toscano A; Lochmüller H Neuromuscul Disord; 2020 Apr; 30(4):336-339. PubMed ID: 32360402 [TBL] [Abstract][Full Text] [Related]
5. CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn. Müller JS; Baumeister SK; Schara U; Cossins J; Krause S; von der Hagen M; Huebner A; Webster R; Beeson D; Lochmüller H; Abicht A Brain; 2006 Oct; 129(Pt 10):2784-93. PubMed ID: 16916845 [TBL] [Abstract][Full Text] [Related]
16. Congenital myasthenic syndrome: a case report. Ceylan A; Tuncer O; Sayin R; Peker E; Caksen H; Sari S Genet Couns; 2011; 22(1):75-8. PubMed ID: 21614992 [TBL] [Abstract][Full Text] [Related]
17. [Clinical and genetic analysis of a patient with slow-channel congenital myasthenic syndrome]. Liu Y; Ye S; Zhang H; Zhang K; Lyu Y; Gao M; Gai Z; Liu Y Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 May; 37(5):551-554. PubMed ID: 32335884 [TBL] [Abstract][Full Text] [Related]
18. Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK. Gallenmüller C; Müller-Felber W; Dusl M; Stucka R; Guergueltcheva V; Blaschek A; von der Hagen M; Huebner A; Müller JS; Lochmüller H; Abicht A Neuromuscul Disord; 2014 Jan; 24(1):31-5. PubMed ID: 24183479 [TBL] [Abstract][Full Text] [Related]
19. Congenital myasthenic syndrome due to mutations in MUSK suggests that the level of MuSK phosphorylation is crucial for governing synaptic structure. Rodríguez Cruz PM; Cossins J; Cheung J; Maxwell S; Jayawant S; Herbst R; Waithe D; Kornev AP; Palace J; Beeson D Hum Mutat; 2020 Mar; 41(3):619-631. PubMed ID: 31765060 [TBL] [Abstract][Full Text] [Related]
20. Structural abnormalities of the AChR caused by mutations underlying congenital myasthenic syndromes. Beeson D; Webster R; Ealing J; Croxen R; Brownlow S; Brydson M; Newsom-Davis J; Slater C; Hatton C; Shelley C; Colquhoun D; Vincent A Ann N Y Acad Sci; 2003 Sep; 998():114-24. PubMed ID: 14592868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]